Here are five recent news updates on key gastroenterology and endoscopy companies.
Boston Scientific elected Donna A. James to its board of directors. Ms. James is the founder and managing director of Lardon & Associates, a business development and executive advisory services firm.
Twenty-five brokerage firms have given Boston Scientific an average rating of "buy" and an average price target of $18.55, according to a Dakota Financial News report.
Four analysts that cover EndoChoice stock have rated the company shares as a "strong buy," according to a WKRB News & Analysis report. The company stock has a one-year consensus price target of $23.33.
Ferring Pharmaceuticals and Intralytix formed a new partnership geared toward developing bacteriophage-based drugs designed to treat inflammatory bowel disease.
gMed, a GI practice and ASC EHR company, held its annual summit meeting in Ft. Lauderdale, Fla., from June 18 to June 20.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at email@example.com.